Eldecalcitol for GLucocorticoid Induced OsteopoRosIs Versus Alfacalcidol

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
The purpose of this study is to evaluate the efficacy and safety of eldecalcitol monotherapy compared with alfacalcidol monotherapy in patients with glucocorticoid-induced osteoporosis, using a randomized, open-label, parallel-group, comparative design.
Epistemonikos ID: 3bdbd7da244785015b5d4e19d414c9610bdece5c
First added on: May 11, 2024